Personal information

Other IDs

Scopus Author ID: 57201526924
Loop profile: 672794
ResearcherID: AAN-4704-2020

Activities

Collapse all

Employment (1)

Tongji Hospital: Wuhan, CN

Employment
Source: Self-asserted source
Ming Yi

Works (13)

Harnessing the evolving CRISPR/Cas9 for precision oncology

Journal of Translational Medicine
2024-08-08 | Journal article
DOI: 10.1186/s12967-024-05570-4
Contributors: Tianye Li; Shuiquan Li; Yue Kang; Jianwei Zhou; Ming Yi
Source: check_circle
Crossref

Identifying Tumorigenesis and Prognosis‐Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis

BioMed Research International
2020-01 | Journal article
DOI: 10.1155/2020/4169691
Contributors: Ming Yi; Tianye Li; Shuang Qin; Shengnan Yu; Qian Chu; Anping Li; Kongming Wu; Rui Liu
Source: check_circle
Crossref

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy

Journal of Hematology and Oncology
2019 | Journal article
DOI: 10.1186/s13045-019-0721-x
EID:

2-s2.0-85063741250
Contributors: Li, A.; Yi, M.; Qin, S.; Song, Y.; Chu, Q.; Wu, K.
Source: Self-asserted source
Ming Yi via Scopus - Elsevier

EYA2 correlates with clinico-pathological features of breast cancer, promotes tumor proliferation, and predicts poor survival

Frontiers in Oncology
2019 | Journal article
DOI: 10.3389/fonc.2019.00026
EID:

2-s2.0-85063253763
Contributors: Xu, H.; Jiao, Y.; Yi, M.; Zhao, W.; Wu, K.
Source: Self-asserted source
Ming Yi via Scopus - Elsevier

Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy

Journal of Hematology and Oncology
2019 | Journal article
DOI: 10.1186/s13045-019-0718-5
EID:

2-s2.0-85062824293
Contributors: Qin, S.; Li, A.; Yi, M.; Yu, S.; Zhang, M.; Wu, K.
Source: Self-asserted source
Ming Yi via Scopus - Elsevier

Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment

Molecular Cancer
2019 | Journal article
DOI: 10.1186/s12943-019-0974-6
EID:

2-s2.0-85063721352
Contributors: Yi, M.; Jiao, D.; Qin, S.; Chu, Q.; Wu, K.; Li, A.
Source: Self-asserted source
Ming Yi via Scopus - Elsevier

The role of gut microbiota in immune checkpoint inhibitor therapy.

Hepatobiliary surgery and nutrition
2018-12 | Journal article
DOI: 10.21037/hbsn.2018.11.12
PMID: 30652094
Contributors: Yi M; Qin S; Chu Q; Wu K
Source: Self-asserted source
Ming Yi via Europe PubMed Central

The role of neoantigen in immune checkpoint blockade therapy.

Experimental Hematology & Oncology
2018-11 | Journal article
DOI: 10.1186/s40164-018-0120-y
PMID: 30473928
PMC: PMC6240277
Contributors: Yi M; Qin S; Zhao W; Yu S; Chu Q; Wu K
Source: Self-asserted source
Ming Yi via Europe PubMed Central
grade
Preferred source (of 2)‎

The regulation of cytokine signaling by retinal determination gene network pathway in cancer.

OncoTargets and therapy
2018-10 | Journal article
DOI: 10.2147/OTT.S176113
PMID: 30323623
PMC: PMC6177397
Contributors: Zheng X; Liu Q; Yi M; Qin S; Wu K
Source: Self-asserted source
Ming Yi via Europe PubMed Central
grade
Preferred source (of 2)‎

Organoid technology and applications in cancer research.

Journal of hematology & oncology
2018-09 | Journal article
DOI: 10.1186/s13045-018-0662-9
PMID: 30219074
PMC: PMC6139148
Contributors: Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
Source: Self-asserted source
Ming Yi via Europe PubMed Central
grade
Preferred source (of 2)‎

Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA.

Cancer Management and Research
2018-09 | Journal article
DOI: 10.2147/CMAR.S170033
PMID: 30319288
PMC: PMC6167987
Contributors: Bai X; Yi M; Xia X; Yu S; Zheng X; Wu K
Source: Self-asserted source
Ming Yi via Europe PubMed Central
grade
Preferred source (of 2)‎

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors.

Molecular cancer
2018-08 | Journal article
DOI: 10.1186/s12943-018-0864-3
PMID: 30139382
PMC: PMC6107958
Contributors: Yi M; Jiao D; Xu H; Liu Q; Zhao W; Han X; Wu K
Source: Self-asserted source
Ming Yi via Europe PubMed Central
grade
Preferred source (of 2)‎

Gut microbiome modulates efficacy of immune checkpoint inhibitors.

Journal of hematology & oncology
2018-03 | Journal article
DOI: 10.1186/s13045-018-0592-6
PMID: 29580257
PMC: PMC5870075
Contributors: Yi M; Yu S; Qin S; Liu Q; Xu H; Zhao W; Chu Q; Wu K
Source: Self-asserted source
Ming Yi via Europe PubMed Central
grade
Preferred source (of 2)‎

Peer review (66 reviews for 7 publications/grants)

Review activity for BioDrugs. (1)
Review activity for Biomedicine & pharmacotherapy. (51)
Review activity for Experimental hematology & oncology. (8)
Review activity for iScience. (1)
Review activity for Journal of translational medicine. (2)
Review activity for Oncology and therapy. (1)
Review activity for World journal of surgical oncology (2)
How many people are using ORCID?